AK Medical Holdings Limited has issued a positive profit alert indicating robust interim performance for the six months ended 30 June 2026. Based on unaudited management accounts, the orthopaedic implant maker projects a revenue increase of about 10% year on year, underpinned by strong momentum in overseas markets and intelligent device sales.

The Group’s overseas revenue is anticipated to leap roughly 40% compared with the same period in 2025, illustrating successful market penetration and growing demand outside China. Management expects these top-line gains to translate into a net profit expansion of more than 20% versus the prior-year interim period.

The Board noted that the interim results are still being finalized and remain subject to audit committee review. Detailed financial statements are scheduled for release by the end of August 2026. Investors are advised to exercise caution in dealing in the Company’s shares until the full interim report is published.